Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law ...

Changes to revenue recognition and lease accounting represent two of the most significant developments in financial reporting in recent years.

The Financial Accounting Standards Board released a post-implementation review Monday of its revenue recognition standard, reflecting on the benefits and costs of the wide-ranging standard a decade ...

CrowdStrike (NASDAQ:CRWD) noted that it received requests for information from the U.S. Department of Justice and the U.S. Securities and Exchange Commission related to the company's recognition of ...

"RevRec360™ is a natural extension of our platform's mission—to help businesses eliminate operational inefficiencies and maintain complete control over their revenue lifecycle," said JK Chelladurai, ...

Analyst Insight: Many biotech firms struggle to manage the order-to-cash (O2C) cycle effectively because large contract manufacturers (CMOs) often handle physical shipping, while the firm retains ...

On Wednesday, Symbotic Inc (NASDAQ:SYM) announced a delay in filing its Annual Report on Form 10-K for the fiscal year ending September 28, 2024. The company cited the need for additional time to ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--RightRev, a cloud-based finance and accounting solutions provider for Revenue Recognition Automation, announced today that it had raised $12 million in funding co ...

The AICPA A&A Focus webcast on May 7 featured timely updates and strategic insights on key accounting and auditing topics. Hosted by Bob Durak, CPA, CMGA, director of A&A Technical Services at the ...

YIT Corporation Stock Exchange Release March 6, 2026, at 8:30 a.m. YIT adopts percentage of completion revenue recognition method in segment reporting and publishes comparison financial information ...

Schrodinger Inc (SDGR) reports a 23% revenue increase and strategic advancements, despite facing margin pressures and a challenging biotech environment.